A
Andreia Valente
Researcher at University of Lisbon
Publications - 54
Citations - 1439
Andreia Valente is an academic researcher from University of Lisbon. The author has contributed to research in topics: Ruthenium & Chain transfer. The author has an hindex of 20, co-authored 48 publications receiving 1190 citations. Previous affiliations of Andreia Valente include university of lille & Centre national de la recherche scientifique.
Papers
More filters
Journal ArticleDOI
Coordinative chain transfer polymerization.
Journal ArticleDOI
DNA interaction and cytotoxicity studies of new ruthenium(II) cyclopentadienyl derivative complexes containing heteroaromatic ligands.
Virtudes Moreno,Mercè Font-Bardia,Teresa Calvet,Julia Lorenzo,Francesc X. Avilés,M. Helena Garcia,Tânia S. Morais,Andreia Valente,M. Paula Robalo +8 more
TL;DR: The cytotoxicity of compounds 1234 was much higher than that of cisplatin against human leukemia cancer cells (HL-60 cells) and IC(50) values for all the compounds are in the range of submicromolar amounts.
Journal ArticleDOI
Isoprene–Styrene Chain Shuttling Copolymerization Mediated by a Lanthanide Half‐Sandwich Complex and a Lanthanidocene: Straightforward Access to a New Type of Thermoplastic Elastomers
TL;DR: A lanthanide half-sandwich complex and a ansa lanthanidocene have been assessed for isoprene-styrene chain shuttling copolymerization with n-butylethylmagnesium (BEM), highlighting a new class of thermoplastic elastomers (TPEs) with tunable transition temperatures.
Journal ArticleDOI
Catalytic Chain Transfer (co-)Polymerization: Unprecedented Polyisoprene CCG and a New Concept to Tune the Composition of a Statistical Copolymer.
TL;DR: Chain transfer in the course of a metal catalyzed statisticalCopolymerization may be viewed as a new and original way for the control of the composition of a copolymer.
Journal ArticleDOI
First polymer "ruthenium-cyclopentadienyl" complex as potential anticancer agent.
Andreia Valente,Maria Helena Garcia,Fernanda Marques,Yong Miao,Cyril Rousseau,Philippe Zinck +5 more
TL;DR: RuPMC was tested against human MCF7 and MDAMB231 breast and A2780 ovarian adenocarcinoma revealing IC50 values in the micromolar range, suggesting potential application of RuPMC as a new drug delivery system for Ru(II)Cp compounds.